Fair Value Calculator Fair Value Calculator
EN DE

CHDCHEM (CHDCHEM) Fair Value & Analysis

IN · Market cap ₹55.8M

C CHDCHEM CHDCHEM · BSE
Price₹5.52
Fair Value₹0.6300
Upside-88.6%
Quality51/100
Watch CHDCHEM for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹0.6300 – ₹2.52

Fair value as of: Jul 5, 2026

From 9 valuation models · updated yesterday

Share price −5.0% over the past month.

Price vs Fair Value (12 months)

₹7.06 ₹4.76 Fair Value ₹0.6300 Jul 2025 Jul 2026

12‑month range ₹4.76 – ₹7.06 · fair‑value band ₹0.6300 – ₹2.52 · the ₹5.52 price screens above the ₹0.6300 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

CHDCHEM (CHDCHEM) currently trades at ₹5.52, while our model-based Fair Value estimate is ₹0.6300 — implying the stock looks roughly 88.6% overvalued today. We read business quality at 51/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, CHDCHEM generated revenue of ₹56.1M at a net margin of -5.6%. Revenue grew 6.7% year over year. It earns a return on equity of -2.4%. Net debt stands at ₹57.4M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹0.6300 (bear case) to ₹2.52 (bull case); at ₹5.52, the current price sits above that range. The share trades about 24% below its 52-week high and 34% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹56.1M
Revenue growth (YoY) +6.7%
Net margin -5.6%
Return on equity -2.4%
Free cash flow ₹4.9M FY2026
Operating margin -2.4%
More key figures
EPS (TTM) ₹-0.3100
EPS growth (YoY) +247%
Net debt ₹57.4M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

CHDCHEM reported revenue of ₹52.5M in FY2026 versus ₹315M in FY2022, a compound −36.1%/yr. Reported net income was −₹3.1M in FY2026.

Revenue −36.1%/yr
FY22 ₹315M
FY23 ₹191M
FY24 ₹162M
FY25 ₹68.8M
FY26 ₹52.5M
Net income
FY22 ₹5.1M
FY23 ₹655K
FY24 ₹2.6M
FY25 −₹2.0M
FY26 −₹3.1M

Is CHDCHEM fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "CHDCHEM Fair Value". https://www.fairvalue-calculator.com/stock/CHDCHEM

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is CHDCHEM (CHDCHEM) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹0.6300 versus a price of ₹5.52 — about −89% (overvalued). Model-based estimate, not financial advice.
What is the fair value of CHDCHEM?
Our model-based fair value for CHDCHEM is ₹0.6300 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹5.52.
What is the quality score of CHDCHEM?
CHDCHEM has a Quality Score of 51/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of CHDCHEM (CHDCHEM)?
CHDCHEM reported trailing-twelve-month revenue of about ₹56.1M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of CHDCHEM?
The net profit margin of CHDCHEM is about -5.6%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.